Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
IPO Year: 2001
Exchange: AMEX
Website: retractable.com
| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
Retractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and employment benefits, or approximately 13% of total estimated workforce costs. The expected savings are offset by estimated one-time separation payments of approximately $122 thousand to the affected workers. Approximately 58% of the targeted payroll reduction affects manufacturing or manufacturing support positions and the remainder of the reductions affects sales and sales support roles. The move comes as the Company continues to strengthen its domestic production capabilities and increase manufacturing e
Retractable Technologies, Inc. (NYSE:RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company's revenues for 2025 increased 15.8%. The Company's revenues were approximately $38.3 million in 2025 as compared to approximately $33.0 million in the prior year. Domestic revenues increased 9.7% principally due to an increase in VanishPoint® and EasyPoint® needle sales. International revenues increased 64.0% predominantly due to higher EasyPoint® needle sales. Compar
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to shareholders of record as of the close of business on April 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cath
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and
Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $5.1 million. For the first nine months of the year, net sales were $28.8 million and operating losses were $13.5 million as compared to 2024 net revenues of $24.0 million and operating losses of $13.9 million. Tariffs continue to have a material impact on our results of operation and financial position. The tariff rate on needles and syringes imported from China as of September 30, 2025 was 130% and the rate on other produ
Retractable Technologies, Inc. (NYSE:RVP) announces its EasyPoint® Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient®, the largest healthcare performance improvement company in the country. Each year, healthcare experts serving on one of Vizient's client-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of he
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2025 through September 30, 2025. The dividends will be paid on October 20, 2025 to shareholders of record as of the close of business on October 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV
Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.4 million for the second quarter of 2025 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $6.0 million and an operating loss of $5.8 million. For the first half of the year, net sales were $18.7 million and operating losses were $9.8 million as compared to 2024 net revenues of $13.6 million and operating losses of $8.7 million. Increased EasyPoint® needle sales in the first six months of 2025 positively affected overall net revenues, but the lower selling price attributable to the products resulted in a reduction of the total average selling price for
Retractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 12.4%. The reduction is expected to save an estimated $1.6 million in annual wages and benefits, or approximately 8.6% of total estimated workforce costs. The expected savings is offset by one-time separation payments of approximately $56 thousand to the affected workers. The reduction targets the Company's manufacturing and manufacturing support positions as the Company continues to balance its domestic manufacturing presence against its reliance on imported products and associated tariffs from its Chinese contract manufacturers. While contract manufacturers in China have historically pro
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shareholders of record as of the close of business on July 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)
8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
10-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
DEFA14A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
DEF 14A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
10-Q - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)
SCHEDULE 13D/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)
Live Leadership Updates
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Conv
Live finance-specific insights
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to shareholders of record as of the close of business on April 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cath
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2025 through September 30, 2025. The dividends will be paid on October 20, 2025 to shareholders of record as of the close of business on October 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shareholders of record as of the close of business on July 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2024 through December 31, 2024. The dividends will be paid on January 20, 2025 to shareholders of record as of the close of business on January 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024 to shareholders of record as of the close of business on October 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2024 through June 30, 2024. The dividends will be paid on July 22, 2024 to shareholders of record as of the close of business on July 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2024 through March 31, 2024. The dividends will be paid on April 22, 2024 to shareholders of record as of the close of business on April 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cath
Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2023 through December 31, 2023. The dividends will be paid on January 22, 2024 to shareholders of record as of the close of business on January 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and
This live feed shows all institutional transactions in real time.
SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)
SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)
SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)
SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)
SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)